e-Drug3D

839

ELETRIPTAN


INN
ELETRIPTAN

cas 143322-58-1
CLASS

NERVOUS SYSTEM
ANTI-MIGRANE
ANTI-INFLAMMATORY AGENTS
SEROTONIN AGONISTS
VASOCONSTRICTOR AGENTS
5-HYDROXYTRYPTAMINE RECEPTOR AGONIST (5HT)

ROUTE (list)

ORAL

ATC code

N02CC06

PK parameters

F 50 PERCENT
Tmax 1.5 HOUR
VD 138 LITER
PPB 85 PERCENT
t1/2 4 HOUR

Solubility

READILY SOLUBLE IN WATER


Target

TARGET 5-HYDROXYTRYPTAMINE 1B RECEPTOR
5-HYDROXYTRYPTAMINE 1D RECEPTOR
5-HYDROXYTRYPTAMINE 1F RECEPTOR

DrugCentral

5-hydroxytryptamine receptor 1B UNIPROT P28222 HTR1B

5-hydroxytryptamine receptor 1D UNIPROT P28221 HTR1D

Download SDF file 3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-5-(2-phenylsulfonylethyl)-1H-indole

Formula:
C22H26N2O2S

Calculated chemical properties:

MW 382.52
NB_atoms 27
XLogP 3.82
PSA 53.496
NB_HD 1
NB_HA 4
fsp3 0.36
Lipinski(0=no;1=yes) 1

FDA
NDA 021016 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) RELPAX (UPJOHN) APPROVAL= AP YEAR= 2002
NDA 201536 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (APOTEX INC) APPROVAL= TA YEAR= 2013
NDA 202040 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2017
NDA 205186 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2017
NDA 205152 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (MYLAN) APPROVAL= AP YEAR= 2017
NDA 206409 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2017
NDA 206787 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (STEVENS J) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 210708 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2019
NDA 209680 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (YUNG SHIN PHARM) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 215467 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (BEXIMCO PHARMS USA) APPROVAL= AP YEAR= 2022
NDA 219143 (pdf not found) INN (ELETRIPTAN HYDROBROMIDE) ELETRIPTAN HYDROBROMIDE (ANNORA PHARMA) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL